These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1429847)
21. Exogenous recombinant human BMP-2 has little initial effects on human osteoblastic cells cultured on collagen type I coated/noncoated hydroxyapatite ceramic granules. Turhani D; Weissenböck M; Stein E; Wanschitz F; Ewers R J Oral Maxillofac Surg; 2007 Mar; 65(3):485-93. PubMed ID: 17307597 [TBL] [Abstract][Full Text] [Related]
22. Pulsed electromagnetic field stimulation of MG63 osteoblast-like cells affects differentiation and local factor production. Lohmann CH; Schwartz Z; Liu Y; Guerkov H; Dean DD; Simon B; Boyan BD J Orthop Res; 2000 Jul; 18(4):637-46. PubMed ID: 11052501 [TBL] [Abstract][Full Text] [Related]
23. Effects of transforming growth factor-beta 1 on murine clonal osteoblastic cells (MC3T3-E1). Okawa M; Hakeda Y; Wakatsuki N; Katoh Y; Higashino K; Kumegawa M Meikai Daigaku Shigaku Zasshi; 1990; 19(3):310-22. PubMed ID: 2134892 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts. Zhou H; Hammonds RG; Findlay DM; Martin TJ; Ng KW J Cell Physiol; 1993 Apr; 155(1):112-9. PubMed ID: 8385674 [TBL] [Abstract][Full Text] [Related]
25. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687 [TBL] [Abstract][Full Text] [Related]
26. Optimization of bone engineering by means of growth factors in a three-dimensional matrix. Arnold U; Schweitzer S; Lindenhayn K; Perka C J Biomed Mater Res A; 2003 Oct; 67(1):260-9. PubMed ID: 14517885 [TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of 1,25(OH)2 vitamin D3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts. Broess M; Riva A; Gerstenfeld LC J Cell Biochem; 1995 Mar; 57(3):440-51. PubMed ID: 7768979 [TBL] [Abstract][Full Text] [Related]
28. Connexin-43 expression in oral-derived human osteoblasts after transforming growth factor-beta and prostaglandin E2 exposure. Adamo CT; Mailhot JM; Smith AK; Borke JL J Oral Implantol; 2001; 27(1):25-31. PubMed ID: 11326538 [TBL] [Abstract][Full Text] [Related]
29. Differential expression of alkaline phosphatase in clones of human osteoblast-like cells. Manduca P; Sanguineti C; Pistone M; Boccignone E; Sanguineti F; Santolini F; Federici A J Bone Miner Res; 1993 Mar; 8(3):291-300. PubMed ID: 8456585 [TBL] [Abstract][Full Text] [Related]
30. Identification of proteins secreted by human osteoblastic cells in culture. Johansen JS; Williamson MK; Rice JS; Price PA J Bone Miner Res; 1992 May; 7(5):501-12. PubMed ID: 1615759 [TBL] [Abstract][Full Text] [Related]
31. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Ingram RT; Bonde SK; Riggs BL; Fitzpatrick LA Differentiation; 1994 Jan; 55(2):153-63. PubMed ID: 8143932 [TBL] [Abstract][Full Text] [Related]
32. Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells. Pfeilschifter J; D'Souza SM; Mundy GR Endocrinology; 1987 Jul; 121(1):212-8. PubMed ID: 3474142 [TBL] [Abstract][Full Text] [Related]
33. In vitro differentiation potential of a new human osteosarcoma cell line (HOS 58). Siggelkow H; Niedhart C; Kurre W; Ihbe A; Schulz A; Atkinson MJ; Hüfner M Differentiation; 1998 Jun; 63(2):81-91. PubMed ID: 9674117 [TBL] [Abstract][Full Text] [Related]
34. Differentiation of normal human bone cells by transforming growth factor-beta and 1,25(OH)2 vitamin D3. Wergedal JE; Matsuyama T; Strong DD Metabolism; 1992 Jan; 41(1):42-8. PubMed ID: 1538645 [TBL] [Abstract][Full Text] [Related]
35. Stimulation of matrix vesicle enzyme activity in osteoblast-like cells by 1,25(OH)2D3 and transforming growth factor beta (TGF beta). Bonewald LF; Schwartz Z; Swain LD; Boyan BD Bone Miner; 1992 May; 17(2):139-44. PubMed ID: 1611299 [TBL] [Abstract][Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells. Nozaki K; Kadosawa T; Nishimura R; Mochizuki M; Takahashi K; Sasaki N J Vet Med Sci; 1999 Jun; 61(6):649-56. PubMed ID: 10423687 [TBL] [Abstract][Full Text] [Related]
37. Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). Bonewald LF; Kester MB; Schwartz Z; Swain LD; Khare A; Johnson TL; Leach RJ; Boyan BD J Biol Chem; 1992 May; 267(13):8943-9. PubMed ID: 1577731 [TBL] [Abstract][Full Text] [Related]
38. The expression of transforming growth factor-beta and interleukin-1beta mRNA and the response to 1,25(OH)2D3' 17 beta-estradiol, and testosterone is age dependent in primary cultures of mouse-derived osteoblasts in vitro. Wang X; Schwartz Z; Yaffe P; Ornoy A Endocrine; 1999 Aug; 11(1):13-22. PubMed ID: 10668636 [TBL] [Abstract][Full Text] [Related]
39. Effects of transforming growth factor-beta on normal clonal bone cell populations. Ber R; Kubota T; Sodek J; Aubin JE Biochem Cell Biol; 1991; 69(2-3):132-40. PubMed ID: 1851616 [TBL] [Abstract][Full Text] [Related]
40. Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. Wrana JL; Maeno M; Hawrylyshyn B; Yao KL; Domenicucci C; Sodek J J Cell Biol; 1988 Mar; 106(3):915-24. PubMed ID: 3162238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]